---
title: "Safety, reactogenicity and immunogenicity of the combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants"
analyst: amantonio
article:
  type: article
  authors: Zepp
  year: 2004
  magazine: Vaccine
  link: https://www.ncbi.nlm.nih.gov/pubmed/15149781
  pubmed: 15149781
---

Clinical trials of Infanrix Hexa vaccine. Safery was tested during 30 days.
Serious adverse events occurred in 79 infants (2.7%). Nearly all of them were not related to the vaccine. One infant died (SIDS). It was not related to the vaccine.
